1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
CD58 |
2 |
34560683 |
10.1097/PAS.0000000000001813 |
2022 |
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. |
CD58 |
3 |
35317330 |
10.14740/wjon1436 |
2022 |
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. |
CD58 |
4 |
35491222 |
10.11406/rinketsu.63.313 |
2022 |
[Epigenetic modification as a therapeutic approach for B-cell lymphoma]. |
CD58 |
5 |
35622145 |
10.1007/s00428-022-03348-x |
2022 |
CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma. |
CD58 |
6 |
35881486 |
10.1172/JCI159402 |
2022 |
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses. |
CD58 |
7 |
33340851 |
10.1016/j.leukres.2020.106491 |
2021 |
Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia. |
CD58 |
8 |
33479306 |
10.1038/s41598-020-80376-0 |
2021 |
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. |
CD58 |
9 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
CD58 |
10 |
33777778 |
10.3389/fonc.2021.628807 |
2021 |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. |
CD58 |
11 |
34339834 |
10.1016/j.critrevonc.2021.103430 |
2021 |
Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review. |
CD58 |
12 |
34937829 |
10.3960/jslrt.21007 |
2021 |
Tumor microenvironment of adult T-cell leukemia/lymphoma. |
CD58 |
13 |
31254446 |
10.1002/cyto.b.21834 |
2020 |
Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting. |
CD58 |
14 |
31962268 |
10.1016/j.molimm.2020.01.006 |
2020 |
EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas. |
CD58 |
15 |
32068791 |
10.1093/ajcp/aqaa007 |
2020 |
Improved Recognition of Hematogones From Precursor B-Lymphoblastic Leukemia by a Single Tube Flow Cytometric Analysis. |
CD58 |
16 |
32322878 |
10.1093/ibd/izaa065 |
2020 |
Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease. |
CD58 |
17 |
32589698 |
10.1182/blood.2020005546 |
2020 |
Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58. |
CD58 |
18 |
31292115 |
10.1182/blood.2019001126 |
2019 |
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. |
CD58 |
19 |
31597848 |
10.11406/rinketsu.60.1229 |
2019 |
[The immune microenvironment in malignant lymphoma]. |
CD58 |
20 |
31934533 |
10.1155/2019/8586354 |
2019 |
Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis. |
CD58 |
21 |
29564225 |
10.3389/fonc.2018.00054 |
2018 |
Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells. |
CD58 |
22 |
29857068 |
10.1016/j.jid.2018.04.038 |
2018 |
Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. |
CD58 |
23 |
29902581 |
10.1016/j.meegid.2018.06.010 |
2018 |
Low responsiveness to a hepatitis B virus vaccine in a Chinese population lacks association with ITGAL, CD58, TNFSF15, CCL15, TGFB3, and BCL6 gene variants. |
CD58 |
24 |
30093402 |
10.1182/blood-2018-03-838524 |
2018 |
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with <i>DUSP22</i> rearrangements. |
CD58 |
25 |
27998726 |
10.1016/j.ajpath.2016.10.007 |
2017 |
Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. |
CD58 |
26 |
28446317 |
10.7534/j.issn.1009-2137.2017.02.051 |
2017 |
[Research Progress on Relationship between CD58 Molecule and ALL and Lymphoma -Review]. |
CD58 |
27 |
28627735 |
10.1111/cas.13303 |
2017 |
Genetic alterations in adult T-cell leukemia/lymphoma. |
CD58 |
28 |
28694326 |
10.1182/blood-2017-02-768234 |
2017 |
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). |
CD58 |
29 |
27069035 |
10.1093/labmed/lmw009 |
2016 |
Hematogones With Lambda Light Chain Restriction in a 4-Year-Old Boy With Burkitt Lymphoma: A Potential Diagnostic Pitfall. |
CD58 |
30 |
27276707 |
10.18632/oncotarget.9793 |
2016 |
Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses. |
CD58 |
31 |
27389058 |
10.1038/leu.2016.161 |
2016 |
Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells. |
CD58 |
32 |
27467287 |
10.1038/gene.2016.30 |
2016 |
CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse. |
CD58 |
33 |
27825110 |
10.18632/oncotarget.13065 |
2016 |
Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors. |
CD58 |
34 |
25582824 |
10.1038/mt.2015.4 |
2015 |
Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression. |
CD58 |
35 |
25800755 |
10.1200/JCO.2014.57.7080 |
2015 |
Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis. |
CD58 |
36 |
25991819 |
10.1158/1078-0432.CCR-14-2116 |
2015 |
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. |
CD58 |
37 |
26106001 |
10.3960/jslrt.55.13 |
2015 |
Mutation Analysis for TP53 in Chronic-Type Adult T-Cell Leukemia/Lymphoma. |
CD58 |
38 |
26194173 |
10.1002/gcc.22276 |
2015 |
Alterations of the CD58 gene in classical Hodgkin lymphoma. |
CD58 |
39 |
26550829 |
10.1159/000431058 |
2015 |
Molecular Pathology of Adult T-Cell Leukemia/Lymphoma. |
CD58 |
40 |
24413734 |
10.1038/ng.2873 |
2014 |
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. |
CD58 |
41 |
25320005 |
10.1158/0008-5472.CAN-14-0643 |
2014 |
Molecular characterization of chronic-type adult T-cell leukemia/lymphoma. |
CD58 |
42 |
22585868 |
10.1158/2159-8290.CD-RW2011-64 |
2012 |
Gene inactivation promotes immune escape in DLBCL. |
CD58 |
43 |
22713438 |
10.1177/120347541201600305 |
2012 |
Biologic therapy in psoriasis: perspectives on associated risks and patient management. |
CD58 |
44 |
20634374 |
10.1182/blood-2008-01-130252 |
2011 |
Human CD14hi monocytes and myeloid dendritic cells provide a cell contact-dependent costimulatory signal for early CD40 ligand expression. |
CD58 |
45 |
21669033 |
10.3727/096368911X580536 |
2011 |
Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line. |
CD58 |
46 |
22137796 |
10.1016/j.ccr.2011.11.006 |
2011 |
Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. |
CD58 |
47 |
18412874 |
10.1111/j.1365-4632.2008.03470.x |
2008 |
Combining systemic retinoids with biologic agents for moderate to severe psoriasis. |
CD58 |
48 |
18809238 |
10.1016/j.exphem.2008.07.003 |
2008 |
Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients. |
CD58 |
49 |
17349557 |
10.1016/j.sder.2006.12.002 |
2007 |
Complications and adverse reactions in the use of newer biologic agents. |
CD58 |
50 |
15737916 |
10.1016/j.meegid.2004.08.006 |
2005 |
Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders. |
CD58 |
51 |
15360006 |
10.1080/10428190310001643358 |
2004 |
Defective immune function of primary effusion lymphoma cells is associated with distinct KSHV gene expression profiles. |
CD58 |
52 |
12671023 |
10.1093/jnci/95.7.548 |
2003 |
Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules. |
CD58 |
53 |
12915579 |
10.1128/jvi.77.17.9669-9684.2003 |
2003 |
Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. |
CD58 |
54 |
12008089 |
10.1016/s0145-2126(01)00198-9 |
2002 |
Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two cases. |
CD58 |
55 |
12215016 |
10.1007/BF02982580 |
2002 |
Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice. |
CD58 |
56 |
11389007 |
10.1182/blood.v97.12.3713 |
2001 |
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. |
CD58 |
57 |
10664622 |
10.1309/BFH5-NCNP-DK3J-DQBH |
2000 |
Angiodestruction and tissue necrosis of skin-involving CD56+ NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. |
CD58 |
58 |
10089910 |
10.1016/s0301-472x(98)00059-9 |
1999 |
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas. |
CD58 |
59 |
10482995 |
10.1038/sj.leu.2401517 |
1999 |
Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma. |
CD58 |
60 |
10791904 |
10.1089/152581699319984 |
1999 |
Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells. |
CD58 |
61 |
9894758 |
NA |
1998 |
Expression patterns of costimulatory molecules on cells derived from human hematological malignancies. |
CD58 |
62 |
9083889 |
10.1023/a:1027374331094 |
1997 |
A novel human monoclonal antibody rapidly induces homotypic cell aggregation and promotes antibody-secreting activity by human B lymphoblastoid cell line IM-9. |
CD58 |
63 |
9498712 |
10.3109/10428199709058339 |
1997 |
Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and expression of adhesion molecules in B-cell derived non-Hodgkin's lymphomas. |
CD58 |
64 |
11725077 |
10.1007/BF02253573 |
1996 |
Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. ii. from cytokines to cell lineage. |
CD58 |
65 |
8806537 |
10.1006/viro.1996.0452 |
1996 |
Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. |
CD58 |
66 |
8917708 |
10.1007/BF00192429 |
1996 |
Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behaviour. |
CD58 |
67 |
11725067 |
10.1007/BF02255217 |
1995 |
Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas. |
CD58 |
68 |
7490134 |
NA |
1995 |
Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line. |
CD58 |
69 |
7866283 |
10.3109/10428199409049732 |
1994 |
Kinetics of the pleiotropic effect of interleukin 4 on the surface properties of human B-lymphoma cells. |
CD58 |
70 |
7681932 |
10.1016/0161-5890(93)90112-o |
1993 |
Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines. |
CD58 |
71 |
8214003 |
NA |
1993 |
Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. |
CD58 |
72 |
8344715 |
10.1016/0165-2478(93)90066-b |
1993 |
The effect of IL-4 on the phenotype of a human B-cell lymphoma line (Farage) lacking immunoglobulin expression. |
CD58 |
73 |
1282031 |
10.1093/intimm/4.11.1283 |
1992 |
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. |
CD58 |
74 |
1317364 |
10.1002/ijc.2910510319 |
1992 |
Expression of integrins and other adhesion molecules in Epstein-Barr virus-transformed B lymphoblastoid cells and Burkitt's lymphoma cells. |
CD58 |
75 |
1372880 |
10.1002/ijc.2910500605 |
1992 |
Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells. |
CD58 |
76 |
1378014 |
10.1002/eji.1830220712 |
1992 |
Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition. |
CD58 |
77 |
1381563 |
NA |
1992 |
Adhesion receptor profile of thymic B-cell lymphoma. |
CD58 |
78 |
1717480 |
10.1083/jcb.115.1.245 |
1991 |
Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2. |
CD58 |
79 |
1721040 |
NA |
1991 |
Expression of the CDw75 (beta-galactoside alpha 2,6-sialyltransferase) antigen on normal blood cells and in B-cell chronic lymphocytic leukaemia. |
CD58 |
80 |
1722139 |
10.1007/BF01741347 |
1991 |
Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes. |
CD58 |
81 |
27463481 |
10.3109/10428199109103380 |
1991 |
Expression of CD11a (LFA-1) on B-chronic Lymphocytic Leukemia and Lymphoma Cells: Correlation with Cell Surface Immunoglobulin Intensity and CD58 (LFA-3) Expression. |
CD58 |
82 |
1691936 |
NA |
1990 |
Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. |
CD58 |
83 |
1698730 |
10.1002/ijc.2910460418 |
1990 |
Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV). |
CD58 |
84 |
2572856 |
10.1016/s0140-6736(89)91498-0 |
1989 |
Leucocyte adhesion to cells in immune and inflammatory responses. |
CD58 |